Supplementary Financial Statement Information (Tables)

12 Months Ended

Dec. 31, 2024

Supplementary Financial Statement Information [Abstract]

Schedule of Research and Development Expenses, Net

a. Research and development expenses – net

		Year ended December 31,
(in thousands)		2024				2023				2022
Payroll and related expenses		$	3,078			$	5,265			$	6,371
Research and development services			5,039				9,853				8,264
Materials			553				1,880				2,044
Share Based Compensation			916				524				876
Depreciation			497				802				740
Other			540				911				1,605
			10,623				19,235				19,900
Israel Innovation Authority participation in research and development costs and royalties payable			-				(223	)			(1,207	)
		$	10,623			$	19,012			$	18,693

Schedule of General and Administrative Expenses

b. General and administrative expenses

		Year ended December 31,
(in thousands)		2024				2023				2022
Payroll expenses		$	831			$	912			$	1,289
Compensation to directors			1,216				887				681
Professional fees			1,029				969				1,294
Office maintenance and office expenses			105				906				402
Insurance			351				567				895
Share Based Compensation			1,149				1,427				1,836
Other			232				471				707
		$	4,913			$	6,139			$	7,104

Schedule of Other Expenses (Income)

c. Other expenses (income)

		Year ended December 31,
(in thousands)		2024				2023				2022
Loss on disposal group of assets held for sale		$	957			$	4,244			$	-
Income from cancelation of uncertain tax positions			(605	)			-				-
		$	352			$	4,244			$	-

Schedule of Fiannce Income (Expenses), Net

d. Finance income (expenses), net

		Year ended December 31,
(in thousands)		2024				2023				2022
Interest income		$	1,069			$	1,565			$	835
(Loss) income related to marketable securities			-				-				(1,983	)
Exchange differences, net			(182	)			(1,224	)			(4,101	)
Bank commissions and other expenses			(13	)			(14	)			(14	)
		$	874			$	327			$	(5,263	)